Nanotechnological approaches for the targeted delivery of CRISPR-Cas systems for genomic modifications, biomolecular sensing, and precision medicine

Mirza Muhammad Faran Ashraf Baig, Wai Tong Chien and Sek Ying Chair

Biomater. Sci., 2025, 13, 4597
DOI: 10.1039/D5BM00711A

Non-viral delivery of the CRISPR/Cas system: DNAversusRNAversusRNP

Yi Lin, Ernst Wagner and Ulrich Lächelt

Biomater. Sci., 2022, 10, 1166
DOI: 10.1039/D1BM01658J

Emerging lipid–polymer hybrid nanoparticles for genome editing

Mariana Gameiro, João F. Mano and Vítor M. Gaspar

Polym. Chem., 2024, 15, 3436
DOI: 10.1039/D4PY00298A

Advanced strategies for CRISPR/Cas9 delivery and applications in gene editing, therapy, and cancer detection using nanoparticles and nanocarriers

Adric Ru Khiing Hii, Xiaole Qi and Zhenghong Wu

J. Mater. Chem. B, 2024, 12, 1467
DOI: 10.1039/D3TB01850D

Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing

Zoya Iqbal, Khurrum Rehman, Jiang Xia, Maryam Shabbir, Muhammad Zaman, Yujie Liang and Li Duan

Biomater. Sci., 2023, 11, 3762
DOI: 10.1039/D2BM01636B

Functionalized chitosan as nano-delivery platform for CRISPR-Cas9 in cancer treatment

Asif Nawaz, Nur Syamimi Ariffin and Tin Wui Wong

Asian Journal of Pharmaceutical Sciences, 2025, 20, 101041
DOI: 10.1016/j.ajps.2025.101041

Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications

Xinmei Liu, Mengyu Gao and Ji Bao

Nanomaterials, 2025, 15, 540
DOI: 10.3390/nano15070540

Let’s make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment

Mobina Bayat and Javid Sadri Nahand

Cell Biol Toxicol, 2024, 40
DOI: 10.1007/s10565-024-09907-z

Autophagy in oral cancer: Promises and challenges (Review)

Zhou Li, Yao Zhang, Jianhua Lei and Yunxia Wu

Int J Mol Med, 2024, 54
DOI: 10.3892/ijmm.2024.5440

The significance of mitochondrial DNA changes during the onset and progression of head and neck squamous cell carcinoma

Amnani Aminuddin, Poh Kuan Wong, Siti Fathiah Masre, Pei Yuen Ng, Muhammad Asyaari Zakaria and Eng Wee Chua

Future Oncology, 2025, 1
DOI: 10.1080/14796694.2025.2521871

Tumor microenvironment based stimuli-responsive CRISPR/Cas delivery systems: A viable platform for interventional approaches

Nanyang Tang, Qian Ning, Zewei Wang, Yifang Tao, Xuhong Zhao and Shengsong Tang

Colloids and Surfaces B: Biointerfaces, 2022, 210, 112257
DOI: 10.1016/j.colsurfb.2021.112257

Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma

Xing-xing Huo, Shu-jie Wang, Hang Song, Ming-de Li, Hua Yu, Meng Wang, Hong-xiao Gong, Xiao-ting Qiu, Yong-fu Zhu and Jian-ye Zhang

Front. Pharmacol., 2021, 12
DOI: 10.3389/fphar.2021.779779

CRISPR-Cas9 Gene Therapy: Non-Viral Delivery and Stimuli-Responsive Nanoformulations

Hyunwoo Lee, Won-Yeop Rho, Yoon-Hee Kim, Hyejin Chang and Bong-Hyun Jun

Molecules, 2025, 30, 542
DOI: 10.3390/molecules30030542

Covalent conjugation and non-covalent complexation strategies for intracellular delivery of proteins using cell-penetrating peptides

Yasaman Behzadipour and Shiva Hemmati

Biomedicine & Pharmacotherapy, 2024, 176, 116910
DOI: 10.1016/j.biopha.2024.116910

Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing

Tianxu Fang, Xiaona Cao, Mysha Ibnat and Guojun Chen

J Nanobiotechnol, 2022, 20
DOI: 10.1186/s12951-022-01570-y

Intelligent nanotherapeutic strategies for the delivery of CRISPR system

Chao Chen, Wu Zhong, Shiyu Du, Yayao Li, Yunfei Zeng, Kunguo Liu, Jingjing Yang, Xiaoxiang Guan and Xin Han

Acta Pharmaceutica Sinica B, 2023, 13, 2510
DOI: 10.1016/j.apsb.2022.12.013

Nanoparticle therapy for head and neck cancers

Caroline Hoffmann, Colette Shen and Christophe Le Tourneau

Current Opinion in Oncology, 2022, 34, 177
DOI: 10.1097/CCO.0000000000000828

Innovative nanoparticle strategies for treating oral cancers

Shahryar Irannejadrankouhi, Hassan Mivehchi, Aisan Eskandari-Yaghbastlo, Seyedeh Tabasom Nejati, Sahand Emrahoglu, Mohammad Nazarian, Farhad Zahedi, Seyed Mahdi Madani and Mohsen Nabi-Afjadi

Med Oncol, 2025, 42
DOI: 10.1007/s12032-025-02728-y

Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer

Yu-Li Lo, Tse-Yuan Wang, Chun-Jung Chen, Yih-Hsin Chang and Anya Lin

Pharmaceutics, 2022, 14, 1759
DOI: 10.3390/pharmaceutics14091759

Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature

Mingxin Cao, Enyu Shi, Hanping Wang, Lujia Mao, Qiqi Wu, Xinming Li, Yanjie Liang, Xiaoying Yang, Yinsong Wang and Changyi Li

IJN, 2022, Volume 17, 4293
DOI: 10.2147/IJN.S377816

Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment

Shiyao Zhou, Yingjie Li, Qinjie Wu and Changyang Gong

MedComm – Biomaterials and Applications, 2024, 3
DOI: 10.1002/mba2.70

Revolutionizing head and neck squamous cell carcinoma treatment with nanomedicine in the era of immunotherapy

Hong-Xia Li, Yu-Wen Gong, Pi-Jun Yan, Yong Xu, Gang Qin, Wei-Ping Wen and Fang-Yuan Teng

Front. Immunol., 2024, 15
DOI: 10.3389/fimmu.2024.1453753

Sequential acid/reduction response of triblock copolymeric nanomicelles to release camptothecin and toll-like receptor 7/8 agonist for orchestrated chemoimmunotherapy

Xiaoyan Ge, Yanyun Hao, Hui Li, Huajun Zhao, Yang Liu, Yutong Liu, Xia Li, Hongfei Chen, Jing Zou, Shiying Zhang, Lingling Huang, Gang Shan and Zhiyue Zhang

J Nanobiotechnol, 2022, 20
DOI: 10.1186/s12951-022-01577-5

Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer

Huimin Zhang, Chunhong Qin, Changming An, Xiwang Zheng, Shuxin Wen, Wenjie Chen, Xianfang Liu, Zhenghua Lv, Pingchang Yang, Wei Xu, Wei Gao and Yongyan Wu

Mol Cancer, 2021, 20
DOI: 10.1186/s12943-021-01431-6

CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer

Sushmaa Chandralekha Selvakumar, K. Auxzilia Preethi, Kehinde Ross, Deusdedit Tusubira, Mohd Wajid Ali Khan, Panagal Mani, Tentu Nageswara Rao and Durairaj Sekar

Mol Cancer, 2022, 21
DOI: 10.1186/s12943-022-01565-1

The CRISPR-Cas revolution in head and neck cancer: a new era of targeted therapy

Mohsen Hashemi, Xaniar Mohmmadi Khanaghah and Javid Sadri Nahand

Funct Integr Genomics, 2025, 25
DOI: 10.1007/s10142-025-01612-2

The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases

Juan Lou, Bin Wang, Junwei Li, Peng Ni, Yuefei Jin, Shuaiyin Chen, Yuanlin Xi, Rongguang Zhang and Guangcai Duan

Mol Biol Rep, 2022, 49, 11301
DOI: 10.1007/s11033-022-07752-z

Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy

Aisha Aziz, Urushi Rehman, Afsana Sheikh, Mohammed A. S. Abourehab and Prashant Kesharwani

Journal of Biomaterials Science, Polymer Edition, 2023, 34, 398
DOI: 10.1080/09205063.2022.2121592

Nano-Drug Delivery Systems in Oral Cancer Therapy: Recent Developments and Prospective

Yun Zhang, Yongjia Wu, Hongjiang Du, Zhiyong Li, Xiaofeng Bai, Yange Wu, Huimin Li, Mengqi Zhou, Yifeng Cao and Xuepeng Chen

Pharmaceutics, 2023, 16, 7
DOI: 10.3390/pharmaceutics16010007

Advanced Research in Cellular Pharmacokinetics and its Cutting-edge Technologies

Lingjuan Lv, Yuyang You, Yeju Liu and Zhihong Yang

CPD, 2022, 28, 3095
DOI: 10.2174/1381612828666220907102606

Research Progress on Gene Editing Based on Nano-Drug Delivery Vectors for Tumor Therapy

Shiwen Xi, Yong-Guang Yang, Jian Suo and Tianmeng Sun

Front. Bioeng. Biotechnol., 2022, 10
DOI: 10.3389/fbioe.2022.873369

Modulating versatile pathways using a cleavable PEG shell and EGFR-targeted nanoparticles to deliver CRISPR-Cas9 and docetaxel for triple-negative breast cancer inhibition

Yu-Li Lo, Ci-Jheng Hong, Chen-Shen Wang and Ching-Ping Yang

Arch. Pharm. Res., 2024, 47, 829
DOI: 10.1007/s12272-024-01514-0

Comprehensive strategies for constructing efficient CRISPR/Cas based cancer therapy: Target gene selection, sgRNA optimization, delivery methods and evaluation

Sathishbabu Paranthaman, Chinnappa A. Uthaiah, Shadab Md and Huda Mohammed Alkreathy

Advances in Colloid and Interface Science, 2025, 341, 103497
DOI: 10.1016/j.cis.2025.103497

Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors

Dengyun Nie, Ting Guo, Miao Yue, Wenya Li, Xinyu Zong, Yinxing Zhu, Junxing Huang and Mei Lin

Biomolecules, 2022, 12, 1239
DOI: 10.3390/biom12091239

Targeting the oral tumor microenvironment by nanoparticles: A review of progresses

Haosheng Zhang, Fangzheng Zhou, Qiuyu Yang and Mudan Huang

Journal of Drug Delivery Science and Technology, 2024, 91, 105248
DOI: 10.1016/j.jddst.2023.105248

Nanotechnology in healthcare, and its safety and environmental risks

Xiaohan Ma, Yaxin Tian, Ren Yang, Haowei Wang, Latifa W. Allahou, Jinke Chang, Gareth Williams, Jonathan C. Knowles and Alessandro Poma

J Nanobiotechnol, 2024, 22
DOI: 10.1186/s12951-024-02901-x

Tumor pH-functionalized and charge-tunable nanoparticles for the nucleus/cytoplasm-directed delivery of oxaliplatin and miRNA in the treatment of head and neck cancer

Yu-Li Lo, Hua-Ching Lin and Wei-Hsuan Tseng

Acta Biomaterialia, 2022, 153, 465
DOI: 10.1016/j.actbio.2022.09.027

New advances in the therapeutic strategy of head and neck squamous cell carcinoma: A review of latest therapies and cutting-edge research

Yuting Wang, Jing Han, Yongxue Zhu, Naisi Huang and Ning Qu

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025, 1880, 189230
DOI: 10.1016/j.bbcan.2024.189230

Development of Inorganic and Hybrid Nanosystems for Delivery of CRISPR-Based Gene Editors

Iulia Spataru, Felix Mahoro and Ildiko Badea

Mol. Pharmaceutics, 2025, 22, 4373
DOI: 10.1021/acs.molpharmaceut.5c00251

Dacarbazine-Loaded Targeted Polymeric Nanoparticles for Enhancing Malignant Melanoma Therapy

Wei Xiong, Zhengdong Guo, Baoyan Zeng, Teng Wang, Xiaowei Zeng, Wei Cao and Daizheng Lian

Front. Bioeng. Biotechnol., 2022, 10
DOI: 10.3389/fbioe.2022.847901

Advances in nanomaterials for the diagnosis and treatment of head and neck cancers: A review

Cheng Yu, Long Li, Shiwen Wang, Yuanhang Xu, Lu Wang, Yongbiao Huang, Ahmed Hieawy, He Liu and Jingzhi Ma

Bioactive Materials, 2023, 25, 430
DOI: 10.1016/j.bioactmat.2022.08.010

Application Perspectives of Nanomedicine in Cancer Treatment

Shanshan Hou, Muhammad Hasnat, Ziwei Chen, Yinong Liu, Mirza Muhammad Faran Ashraf Baig, Fuhe Liu and Zelong Chen

Front. Pharmacol., 2022, 13
DOI: 10.3389/fphar.2022.909526

The application of CRISPR/Cas9–based genome-wide screening to disease research

Xiuqin Chen, Min Zheng, Su Lin, Meiqing Huang, Shaoying Chen and Shilong Chen

Molecular and Cellular Probes, 2025, 79, 102004
DOI: 10.1016/j.mcp.2024.102004